Schizophrenia Flashcards
(49 cards)
What structural changes take place
Enlarging of ventricles
Decrease in grey matter
decrease in white matter
What is lost in whit matter and what does it Cause
Oligodendrocytes
Loss of myelin sheath and neuronal insulation
signals can transduce and signal
Are neurons lost in schozophrenia
No
Same number
just loss of function
What causes the neurons to become dysfunctional
Loss of myelin sheath –> oligodendrocytes
Dendritic pruning
What are the 2 hypothesis for pathophysiology of schozi
Dopamine
Glutamate
What are the 4 pathways in the pathophysiology
mesolimbic
neocortical
nigrostriatal
Tubular infundibular
What pathway is responsible for positive synptoms
Mesolimbic
What pathway is responsible for negative symptoms
Mesocortical
What function does the mesocortical pathway have
cognitive
What function does the mesolimbic pathway have
Behavioural
reward pathway
What function does the nigral striatal pathway have
Motor coordination
Where do the mesolimbic and mesocortical pathway both start from
VTA
venteral tegmental area
what pathway is associated with prolactin production
Tuberinfundibular
Where are the 5-HT2a receptors found
Nigrostriatal pathway
Summarise why a decrease in glutamate can cause schizophrenia
Decreased glutaminergic signalling
decreased NMDA activity
Decreased GABA production as no glutamate to stimulate release
Decrease in GABA = Increase in mesolimbic activity
induced psychosis symptoms
What are the 4 drug targets used in treatment
D2 ANTAGONIST
5-HT2a ANTAGONIST
alpha-2 ANTAGONIST
Mu ANTAGONIST
How do D2 Antagonists help
Reduces dopamine levels
Mesolimbic –> block reward pathway, decrease in positive symptoms
mesocortical –> No impact as already D2 deficient
Nigrostriatal –> motor symptoms such as pseudoparkinsons
Tubular infundibular –> Increase in prolactin production as dopamine usually inhibits this
How do 5-HT2a Antagonists help
5-HT2a usually inhibits dopamine
inhibiting 5-HT2a means dopamine can be released in nigrostriatal and reduce motor symptoms –. decrease in epse
Increases dopamine and glutamate in mesocortical pathway –> reduced -ve symptoms
What is a consequence of alpha-2 antagonist
Hypotension due to vessels not being able to constrict
How do muscarinic antagonists affect the body
Inhibit acetylcholine in nigrostriatal pathway
balances out the reduction in dopamine with a reduction in acetylcholine
reduces epses
such as cholinergic burden
What are some of the positive symptoms
Hallucinations –> visual, auditory
Delusions –> grandeur, superiority
Disorganised speech
What are some of the negative symptoms
Low mood
lack of enjoyment
lack of emotion
self neglect
lack of apathy
What diagnosis tools do we use
DSM-5
ICD-11
Give some examples of SGA
Olanzapine
quietiapine
Aripiprazole
Clozapine
Rispiradone